From Models to Medicine

Episode 26: Bigger Models Won't Save Biomanufacturing

We sit down with Shawn Manchester, CEO of TripleBar, whose path from yeast DNA repair to metabolic engineering at MIT to biomanufacturing AI gave him a front-row seat to

Episode 25: The 200-Page Protocol Problem AI Is Finally Solving

In this episode of From Models to Medicine, we sit down with Angie Schwab, CEO and founder of Trialynx, who has spent 20 years watching clinical trials run over budget, o

Episode 24: Beyond Correlation - Teaching AI the Rules of Biology

This week, we sit down with Jean-Baptiste Morlot of Deep Life, who makes the case that the drug discovery field has been asking the wrong thing of its AI models. Correlat

Episode 23: When Biologists Start Thinking Like Engineers

This week, we sit down with Katie Lennon, CSO of Exthymic, who makes a case most bench scientists aren't ready to hear: biology isn't just a discovery discipline anymore.

Episode 22: The Model Was Never Built for Her

In this episode of From Models to Medicine, we sit down with Mark Amouzgar, co-founder and CEO of March Health. Mark opens with a striking stat: general-purpose AI models

Episode 21: Glass Box Wins - What Pharma Actually Trusts in AI

In this episode of From Models to Medicine, we sit down with Lavanya Anandan, Head of External Innovation, West Coast at CSL, whose path from bench scientist to Merck Gro

Episode 20: The Build vs. Buy Question Every Pharma Leader is Wrestling With

We chat with Karl Moritz, CEO of Reliant AI, now part of Cohere, whose career took him from NLP research to McKinsey to building AI infrastructure for drug development. K

Episode 19: Flow Cytometry, Biomarkers, and the AI Patterns Nobody Is Verifying

For this episode, we sit down with Banishree Saha, Global Biomarkers Lead at Takeda, who has worked in fields such as academic liver biology to translational biomarker wo

Episode 18: Why Does mRNA Keep Breaking AI Models?

In this episode, we sit down with Chris Nelson, an mRNA scientist at nCode Bio whose career has taken him from building blood transfusion matching tests now used by the N

Episode 17: Garbage Data, Toxic Exposure, and the AI Gap in Environmental Health

In this episode of From Models to Medicine, we sit down with Sarah Daniels, an environmental health researcher, who makes the argument that the chemicals making us sick m

Episode 16: Why Chemistry has Held Drug Discovery Back

Stan Jastrzębski is the co-founder of molecule.one and a deep learning researcher who made a deliberate pivot into synthetic chemistry. In this episode, he explains why c

Episode 15: Stacking AI with Quantum in the Sciences

Anna Benefiel has spent over 20 years in healthcare innovation, and she's tired of watching life sciences sit on the sidelines of quantum computing. In this episode, she

Episode 14: The Drug Discovery Problems AI Alone Can't Solve

In this episode of From Models to Medicine, we speak with Vid Stojevic, the co-founder and CEO of Kuano, a Cambridge-based company using quantum algorithms and AI to tack

Episode 13: The Microbiome is Messier Than You Think

Jenny Yang is the co-founder and CEO of Outpost Bio, where her team is working to make human microbiology computable. In this episode, she breaks down why bias in ML mode

Episode 12: Your Life Sciences Data Isn't Ready for AI

Bogdan Knezevic is the CEO and co-founder of Kaleidoscope Bio, and he's seen enough failed AI implementations to know where they almost always break down. In this episode

Episode 11: From the Gut to the Brain - Rethinking Parkinson's with AI

In this episode of From Models to Medicine, we sit down with Minna Schmidt, a postdoctoral researcher at the Buck Institute for Research on Aging. Minna walks us through

Episode 10: When AI Gets It Wrong, Patients Pay the Price

In this episode of From Models to Medicine, we sit down with Sal Tejani, Associate Director for Field Medical Affairs at Regeneron*, who started his career catching dange

Episode 9: Mitochondria, Machine Learning, and a Few Hard Lessons

Rachel Jacobson has spent her career moving between some of the most demanding corners of life sciences before founding Powerhouse Biology. In this episode, she traces th

Episode 8: The Equity Gap in Diagnostic AI

In this episode, we sit down with Dr. Freddy Nguyen, CEO and co-founder of Nine Diagnostics, whose background spans medicine, pathology, optics, and nanotechnology. Fredd

Episode 7: AI at the Bench: The New Wet Lab Workflow

In this episode of From Models to Medicine, we sit down with Elisa Martin Perez, a postdoc at University of California, Berkeley, to talk about how non-coders are startin